Ajanta Pharma USA recalls 200mg Fenofibrate capsules due to CGMP deviations. Consumers should check NDC 27241-120-04 and lot # PA02216 for affected units.
CGMP Deviations
Ajanta Pharma USA is recalling 200mg Fenof:ibrate capsules that were manufactured with CGMP deviations. This recall affects consumers who may have purchased these capsules from pharmacies or hospitals.
CGMP deviations refer to failures in the manufacturing process that could affect product quality and safety. These deviations might lead to inconsistent drug strength or impurities that could cause health risks.
People who have purchased the 200mg Fenofibrate capsules with NDC 27241-120-04 and lot # PA02216 are affected. Prescriptions for this medication are typically for specific medical conditions.
Check for the NDC code 27241-120-04 and lot number PA02216 on the product packaging. The capsules are labeled as 200mg, prescription-only, and manufactured by Ajanta Pharma Limited in India.
Look for the NDC code 27241-120-04 and lot number PA02216 on the capsule packaging.
The recall is due to CGMP deviations, which could affect product quality and safety. The manufacturer has not provided specific safety details for this product.
Check the NDC code 27241-120-04 and lot number PA02216 on the product packaging.
The recall does not specify a remedy, so the manufacturer has not provided instructions for disposal or return.
We’ve drafted a message you can send Ajanta Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0611-2026 — Ajanta Pharma Ajanta Pharma Hello, I own a Ajanta Pharma that is covered by recall D-0611-2026 from Ajanta Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
